Comparison of Standard and Transepithelial Corneal Cross-Linking for the Treatment of Keratoconus: A Meta-analysis

Purpose. To compare the clinical results of standard corneal cross-linking (SCXL) with transepithelial corneal cross-linking (TECXL) in progressive keratoconus using a meta-analysis. Methods. PubMed, EMBASE, and Cochrane Central Register of Controlled Trials were searched up to June 2020 to identify...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Di, Jingyi Wang, Ying Li, Yang Jiang
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2021/6679770
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565984814170112
author Yu Di
Jingyi Wang
Ying Li
Yang Jiang
author_facet Yu Di
Jingyi Wang
Ying Li
Yang Jiang
author_sort Yu Di
collection DOAJ
description Purpose. To compare the clinical results of standard corneal cross-linking (SCXL) with transepithelial corneal cross-linking (TECXL) in progressive keratoconus using a meta-analysis. Methods. PubMed, EMBASE, and Cochrane Central Register of Controlled Trials were searched up to June 2020 to identify relevant studies. The PRISMA guidelines were followed. Primary outcomes were change in uncorrected distance visual acuity and maximum keratometry (Kmax) after CXL. Secondary outcomes were change in corrected distance visual acuity, mean refractive spherical equivalent (MRSE), spherical and cylindrical error, endothelial cells density (ECD), and central corneal thickness (CCT). Results. Sixteen studies with a total of 690 eyes (SCXL: 332 eyes; TECXL: 358 eyes) were included. At the last follow-up, SCXL provided a greater decrease in maximum keratometry (Kmax) than TECXL (weighted mean difference (WMD) −1.12; 95% confidence interval (CI) −1.96, −0.29). For the other outcomes, there were no statistically significant differences. Conclusions. Except for a greater decrease in Kmax with SCXL group, both groups have a comparable effect on visual, pachymetric, and endothelial parameters at 24 months after surgery. Larger studies with a longer follow-up time are necessary to determine whether these techniques are comparable in the long term.
format Article
id doaj-art-36e06203c23e4e55b2cb6acaa4bdbf9f
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-36e06203c23e4e55b2cb6acaa4bdbf9f2025-02-03T01:05:26ZengWileyJournal of Ophthalmology2090-004X2090-00582021-01-01202110.1155/2021/66797706679770Comparison of Standard and Transepithelial Corneal Cross-Linking for the Treatment of Keratoconus: A Meta-analysisYu Di0Jingyi Wang1Ying Li2Yang Jiang3Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, ChinaDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, ChinaDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, ChinaDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, ChinaPurpose. To compare the clinical results of standard corneal cross-linking (SCXL) with transepithelial corneal cross-linking (TECXL) in progressive keratoconus using a meta-analysis. Methods. PubMed, EMBASE, and Cochrane Central Register of Controlled Trials were searched up to June 2020 to identify relevant studies. The PRISMA guidelines were followed. Primary outcomes were change in uncorrected distance visual acuity and maximum keratometry (Kmax) after CXL. Secondary outcomes were change in corrected distance visual acuity, mean refractive spherical equivalent (MRSE), spherical and cylindrical error, endothelial cells density (ECD), and central corneal thickness (CCT). Results. Sixteen studies with a total of 690 eyes (SCXL: 332 eyes; TECXL: 358 eyes) were included. At the last follow-up, SCXL provided a greater decrease in maximum keratometry (Kmax) than TECXL (weighted mean difference (WMD) −1.12; 95% confidence interval (CI) −1.96, −0.29). For the other outcomes, there were no statistically significant differences. Conclusions. Except for a greater decrease in Kmax with SCXL group, both groups have a comparable effect on visual, pachymetric, and endothelial parameters at 24 months after surgery. Larger studies with a longer follow-up time are necessary to determine whether these techniques are comparable in the long term.http://dx.doi.org/10.1155/2021/6679770
spellingShingle Yu Di
Jingyi Wang
Ying Li
Yang Jiang
Comparison of Standard and Transepithelial Corneal Cross-Linking for the Treatment of Keratoconus: A Meta-analysis
Journal of Ophthalmology
title Comparison of Standard and Transepithelial Corneal Cross-Linking for the Treatment of Keratoconus: A Meta-analysis
title_full Comparison of Standard and Transepithelial Corneal Cross-Linking for the Treatment of Keratoconus: A Meta-analysis
title_fullStr Comparison of Standard and Transepithelial Corneal Cross-Linking for the Treatment of Keratoconus: A Meta-analysis
title_full_unstemmed Comparison of Standard and Transepithelial Corneal Cross-Linking for the Treatment of Keratoconus: A Meta-analysis
title_short Comparison of Standard and Transepithelial Corneal Cross-Linking for the Treatment of Keratoconus: A Meta-analysis
title_sort comparison of standard and transepithelial corneal cross linking for the treatment of keratoconus a meta analysis
url http://dx.doi.org/10.1155/2021/6679770
work_keys_str_mv AT yudi comparisonofstandardandtransepithelialcornealcrosslinkingforthetreatmentofkeratoconusametaanalysis
AT jingyiwang comparisonofstandardandtransepithelialcornealcrosslinkingforthetreatmentofkeratoconusametaanalysis
AT yingli comparisonofstandardandtransepithelialcornealcrosslinkingforthetreatmentofkeratoconusametaanalysis
AT yangjiang comparisonofstandardandtransepithelialcornealcrosslinkingforthetreatmentofkeratoconusametaanalysis